Myocardial Infarction: Clinical Trials

8 trials for Myocardial Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 terminated. 8 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Terminated 8
Phase 25Terminated 5

Follow Myocardial Infarction: new trials by email Literature Review of Myocardial Infarction trials Research Report on Myocardial Infarction

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Compare the Pharmacokinetics and Pharmacodynamics of ASA Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Adult Subjects With Obstructive or Restrictive Pulmonary Function
single dose (100 mg) of ASA, single dose (162 mg) of non-enteric-coated chewable aspirin tablets - Obstructive Pulmonary Function, Restrictive Pulmonary Function
Phase 1TerminatedVectura, Inc.42023-03-112024-03-22
Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration
CAP-1002 Allogeneic Cardiosphere-Derived Cells, Placebo - Myocardial Infarction
Phase 1 / Phase 2TerminatedCapricor Inc.1352012-11-132024-04-09
Autologous Cell Therapy for Ischemic Heart Failure
AMDC - Ischemic Heart Disease
Phase 1 / Phase 2TerminatedCook MyoSite92011-02-052021-07-01
The Effects of Lovaza® in Acute Myocardial Infarction
Lovaza®, The placebo contained 1 gram of corn oil in each capsule. - Myocardial Infarction
Phase 1 / Phase 2TerminatedUniversity of Rochester42010-06-012017-11-06
Effects of Intracoronary Progenitor Cell Therapy on Coronary Flow Reserve After Acute MI
autologous bone marrow-derived progenitor cells, placebo medium - Coronary Artery Disease, Acute Myocardial Infarction
Phase 1 / Phase 2TerminatedJohann Wolfgang Goethe University Hospital312008-09-012017-01-12
Stem Cell Study for Subjects With Congestive Heart Failure
Intramyocardial injection of autologous CD34-positive cells (stem cells) - Myocardial Ischemia, Congestive Heart Failure
Phase 1TerminatedLosordo, Douglas, M.D.42008-03-012015-03-31
Stem Cell Study for Patients With Heart Disease
Autologous peripheral blood CD34 positive cell therapy - Chest Pain, Chronic Myocardial Ischemia
Phase 1 / Phase 2TerminatedFoundation for Biomedical Research and Innovation12005-09-012011-06-22
BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling
Human BNP - Myocardial Infarction
Phase 1TerminatedMayo Clinic242002-08-012009-12-11

Narrower conditions

Heart Failure (3)  ·  Coronary Artery Disease (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)  ·  Acute Coronary Syndrome (1)  ·  Angina Pectoris (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Chest Pain (1)  ·  Non-ST Elevated Myocardial Infarction (1)  ·  Pain (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Aspiration (1)  ·  Vascular Diseases (1)

Broader conditions

Infarction (8)  ·  Ischemia (8)  ·  Necrosis (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Cardiovascular Diseases (7)  ·  Vascular Diseases (7)  ·  Heart Diseases (6)  ·  Myocardial Ischemia (6)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Coronary Disease (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Lung Diseases (1)

Interventions

Corn Oil (1)  ·  Fish Oils (1)  ·  Omacor (1)

Sponsors

Capricor Inc. (1)  ·  Cook MyoSite (1)  ·  Foundation for Biomedical Research and Innovation (1)  ·  Johann Wolfgang Goethe University Hospital (1)  ·  Losordo, Douglas, M.D. (1)  ·  Mayo Clinic (1)  ·  University of Rochester (1)  ·  Vectura, Inc. (1)

Countries

United States (5)  ·  Canada (1)  ·  Germany (1)  ·  Japan (1)

Top investigators

Andreas M Zeiher, MD (1)  ·  Douglas W. Losordo, M.D. (1)  ·  Frank Litvack, MD (1)  ·  Horng H. Chen, M.D. (1)  ·  Hung Q. Ly, MD (1)  ·  Robert Block, MD, MPH (1)  ·  Takayuki Asahara, M.D. (1)

Results publications

PMID 32749459, PMID 34233913

NIH funding

RC3HL103356-01 (1)